These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 27768960)
1. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases. Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960 [TBL] [Abstract][Full Text] [Related]
2. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease. Díaz M; Fabelo N; Martín V; Ferrer I; Gómez T; Marín R J Alzheimers Dis; 2015; 43(4):1185-98. PubMed ID: 25147112 [TBL] [Abstract][Full Text] [Related]
3. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions. Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671 [TBL] [Abstract][Full Text] [Related]
4. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. Martín V; Fabelo N; Santpere G; Puig B; Marín R; Ferrer I; Díaz M J Alzheimers Dis; 2010; 19(2):489-502. PubMed ID: 20110596 [TBL] [Abstract][Full Text] [Related]
5. "Lipid raft aging" in the human frontal cortex during nonpathological aging: gender influences and potential implications in Alzheimer's disease. Díaz M; Fabelo N; Ferrer I; Marín R Neurobiol Aging; 2018 Jul; 67():42-52. PubMed ID: 29627763 [TBL] [Abstract][Full Text] [Related]
6. Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Fabelo N; Martín V; Santpere G; Marín R; Torrent L; Ferrer I; Díaz M Mol Med; 2011; 17(9-10):1107-18. PubMed ID: 21717034 [TBL] [Abstract][Full Text] [Related]
7. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein. Harris B; Pereira I; Parkin E Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113 [TBL] [Abstract][Full Text] [Related]
8. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease. Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729 [TBL] [Abstract][Full Text] [Related]
9. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Marui W; Iseki E; Kato M; Akatsu H; Kosaka K Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts. Cheng H; Vetrivel KS; Gong P; Meckler X; Parent A; Thinakaran G Nat Clin Pract Neurol; 2007 Jul; 3(7):374-82. PubMed ID: 17611486 [TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores. Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711 [TBL] [Abstract][Full Text] [Related]
13. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy. Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334 [TBL] [Abstract][Full Text] [Related]
14. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165 [TBL] [Abstract][Full Text] [Related]
15. The C99 domain of the amyloid precursor protein resides in the disordered membrane phase. Capone R; Tiwari A; Hadziselimovic A; Peskova Y; Hutchison JM; Sanders CR; Kenworthy AK J Biol Chem; 2021; 296():100652. PubMed ID: 33839158 [TBL] [Abstract][Full Text] [Related]
16. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. Ehehalt R; Keller P; Haass C; Thiele C; Simons K J Cell Biol; 2003 Jan; 160(1):113-23. PubMed ID: 12515826 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterol and Alzheimer's disease]. Kálmán J; Janka Z Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374 [TBL] [Abstract][Full Text] [Related]